2913 Kaltenbach, Karol - Thomas Jefferson University - Thomas Jefferson University

Karol Kaltenbach, PhD

Contact Dr. Kaltenbach

1233 Locust Street
Suite 401
Philadelphia, PA 19107

(215) 955-4068

Most Recent Peer-reviewed Publications

  1. The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations
  2. Response to Wouldes and Woodward: Maternal methadone dose during pregnancy and infant clinical outcome
  3. Induction of pregnant women onto opioid-agonist maintenance medication: An analysis of withdrawal symptoms and study retention
  4. Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes
  5. A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine
  6. Opioid dependence during pregnancy: Relationships of anxiety and depression symptoms to treatment outcomes
  7. Buprenorphine treatment of opioid-dependent pregnant women: A comprehensive review
  8. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication
  9. Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurement.
  10. Maternal opioid treatment: Human experimental research (mother)-approach, issues and lessons learned
  11. Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression
  12. Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine
  13. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates
  14. Fetal assessment before and after dosing with buprenorphine or methadone
  15. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication
  16. Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy
  17. Neonatal abstinence syndrome
  18. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: Can we assure the safety of the fetus
  19. Methadone and buprenorphine for the management of opioid dependence in pregnancy
  20. Cigarette smoking and neonatal outcomes in depressed and nondepressed opioid-dependent agonist-maintained pregnant patients